P. Comp

发表

Oral contraceptives and gender affect protein S status.

L. Boerger, P. Morris, G. Thurnau, 1987, Blood.

The regulation of hemostasis: the protein C system.

P. Comp, L. Clouse, 1986, The New England journal of medicine.

Generation of fibrinolytic activity by infusion of activated protein C into dogs.

C. Esmon, P. Comp, 1981, The Journal of clinical investigation.

On the role of phosphatidylethanolamine in the inhibition of activated protein C activity by antiphospholipid antibodies.

Naomi, Douglas, C. Esmon, 1995, The Journal of clinical investigation.

Antibodies to thrombomodulin are found in patients with lupus anticoagulant and unexplained thrombosis.

C. Esmon, P. Comp, N. Esmon, 2000, The Journal of rheumatology.

Traces of factor VIIa modulate thromboplastin sensitivity to factors V, VII, X, and prothrombin

P. Comp, J. Morrissey, S. Smith, 2006, Journal of thrombosis and haemostasis : JTH.

Relationship between protein C antigen and anticoagulant activity during oral anticoagulation and in selected disease states.

Silvana, C. Esmon, P. Comp, 1986, The Journal of clinical investigation.

Activated protein C inhibits platelet prothrombin-converting activity.

C. Esmon, P. Comp, C. T. Esmon, 1979, Blood.

Blockade of protein C activation reduces microvascular surgical blood loss.

P. Comp, L. Pennington, S. Smith, 1992, The Journal of surgical research.

Activation of protein C in vivo.

C. Esmon, P. Comp, G. Ferrell, 1982, The Journal of clinical investigation.

A lysine-absorbable plasminogen activator is elevated in conditions associated with increased fibrinolytic activity.

P. Comp, R. Radcliffe, R. Jacocks, 1981, The Journal of laboratory and clinical medicine.

Some clotting factors in plasma during danazol therapy: free and total protein S, but not C4b-binding protein, are elevated by danazol therapy.

P. Comp, J. A. Evans, O. Ratnoff, 1992, The Journal of laboratory and clinical medicine.

Determination of functional levels of protein C, an antithrombotic protein, using thrombin-thrombomodulin complex.

C. Esmon, P. Comp, R. Nixon, 1984, Blood.

Role of platelets in lysis of dilute plasma clots: requirement for metabolically active platelets.

P. Comp, F. Taylor, M. Lockhart, 1979, The Journal of laboratory and clinical medicine.

Heparin-protein C interaction.

P. Comp, 1984, Nouvelle revue francaise d'hematologie.

Recurrent venous thromboembolism in patients with a partial deficiency of protein S.

C. Esmon, P. Comp, 1984, The New England journal of medicine.

Protein S deficiency occurs in the nephrotic syndrome.

C. Esmon, P. Comp, A. D’Angelo, 1987, Annals of internal medicine.

An abnormal plasma distribution of protein S occurs in functional protein S deficiency.

C. Esmon, P. Comp, D. Patton, 1986, Blood.

Familial protein S deficiency is associated with recurrent thrombosis.

C. Esmon, P. Comp, R. Nixon, 1984, The Journal of clinical investigation.

Functional and immunologic protein S levels are decreased during pregnancy.

P. Comp, C. Esmon, J. Welsh, 1986, Blood.

Acquired deficiencies of protein S. Protein S activity during oral anticoagulation, in liver disease, and in disseminated intravascular coagulation.

C. Esmon, P. Comp, A. D’Angelo, 1988, The Journal of clinical investigation.

Phospholipid composition controls thromboplastin sensitivity to individual clotting factors

P. Comp, J. Morrissey, P. Comp, 2006, Journal of thrombosis and haemostasis : JTH.

The dilute whole blood clot lysis assay: a screening method for identifying postoperative patients with a high incidence of deep venous thrombosis.

P. Comp, F. Taylor, R. Jacocks, 1979, The Journal of laboratory and clinical medicine.

A 5.3-kb deletion including exon XIII of the protein S alpha gene occurs in two protein S-deficient families.

R. Marlar, P. Comp, G. Long, 1991, Blood.

The natural anticoagulant protein S is decreased in male smokers.

C. Esmon, P. Comp, B. D. Scott, 1991, American heart journal.

Anticoagulation proteins C and S.

C. Esmon, P. Comp, A. D’Angelo, 1987, Advances in experimental medicine and biology.

Decrease in endothelial cell-dependent protein C activation induced by thrombomodulin by treatment with cyclosporine.

P. Comp, C. Kaufman, M. Garcia-Maldonado, 1991, Transplantation.

Quantitation of activated factor VII levels in plasma using a tissue factor mutant selectively deficient in promoting factor VII activation.

P. Comp, J H Morrissey, P C Comp, 1993, Blood.

Quantitation of activated factor VII levels in plasma using a tissue factor mutant selectively deficient in promoting factor VII activation

P. Comp, P. Neuenschwander, B. G. Macik, 1993 .

Protein C, isolation and potential use in prevention of thrombosis.

C. Esmon, P. Comp, G. Ferrell, 1987, Developments in biological standardization.